North America Epilepsy Treatment Drugs Market, 2034

North America Epilepsy Treatment Drugs Market - By Drug Class, By Route of Administration, By Age group, By Seizure Type, By Distribution Channel - Regional Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Drug class trends

2.2.2&nbsp;&nbsp;&nbsp; Type trends

2.2.3&nbsp;&nbsp;&nbsp; Route of administration trends

2.2.4&nbsp;&nbsp;&nbsp; Age group trends

2.2.5&nbsp;&nbsp;&nbsp; Seizure type trends

2.2.6&nbsp;&nbsp;&nbsp; Distribution channel trends

2.2.7&nbsp;&nbsp;&nbsp; Country trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.1.1&nbsp;&nbsp;&nbsp; Supplier landscape

3.1.2&nbsp;&nbsp;&nbsp; Value addition at each stage

3.1.3&nbsp;&nbsp;&nbsp; Factor affecting the value chain

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of epilepsy in the region

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing aging population in North America

3.2.1.3&nbsp;&nbsp;&nbsp; Growing demand for novel treatment for epilepsy

3.2.1.4&nbsp;&nbsp;&nbsp; Rising government policies and funding

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of treatment

3.2.2.2&nbsp;&nbsp;&nbsp; Patent expiration

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Digital health and tele-epilepsy integration

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technology landscape

3.4.1&nbsp;&nbsp;&nbsp; Current technological trends

3.4.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Canada

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Pipeline analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy outlook matrix

4.7&nbsp;&nbsp;&nbsp; Key developments

4.7.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.7.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.7.3&nbsp;&nbsp;&nbsp; New product launches

4.7.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Drug Class, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; First-generation

5.3&nbsp;&nbsp;&nbsp; Second-generation

5.4&nbsp;&nbsp;&nbsp; Third-generation

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Branded

6.3&nbsp;&nbsp;&nbsp; Generics

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Oral

7.3&nbsp;&nbsp;&nbsp; Nasal

7.4&nbsp;&nbsp;&nbsp; Injectable

7.5&nbsp;&nbsp;&nbsp; Rectal

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pediatric

8.3&nbsp;&nbsp;&nbsp; Adult

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Seizure Type, 2021 - 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Focal seizure

9.3&nbsp;&nbsp;&nbsp; Generalized seizure

9.4&nbsp;&nbsp;&nbsp; Combined seizure

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

10.3&nbsp;&nbsp;&nbsp; Retail pharmacies

10.4&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 11&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Country, 2021 - 2034 ($ Mn)

11.1&nbsp;&nbsp;&nbsp; Key trends

11.2&nbsp;&nbsp;&nbsp; U.S.

11.3&nbsp;&nbsp;&nbsp; Canada

Chapter 12&nbsp;&nbsp;&nbsp;Company Profiles

12.1&nbsp;&nbsp;&nbsp; AbbVie

12.2&nbsp;&nbsp;&nbsp; Bausch Health Companies

12.3&nbsp;&nbsp;&nbsp; Dr. Reddy&rsquo;s Laboratories

12.4&nbsp;&nbsp;&nbsp; Eisai

12.5&nbsp;&nbsp;&nbsp; GSK

12.6&nbsp;&nbsp;&nbsp; Jazz Pharmaceuticals

12.7&nbsp;&nbsp;&nbsp; Lupin Pharmaceuticals

12.8&nbsp;&nbsp;&nbsp; Neurelis

12.9&nbsp;&nbsp;&nbsp; Novartis

12.10&nbsp;&nbsp;&nbsp; Pfizer

12.11&nbsp;&nbsp;&nbsp; Sanofi

12.12&nbsp;&nbsp;&nbsp; SK Biopharmaceuticals

12.13&nbsp;&nbsp;&nbsp; Sumitomo Pharma

12.14&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries

12.15&nbsp;&nbsp;&nbsp; UCB

&nbsp;&nbsp;&nbsp;

North America Epilepsy Treatment Drugs Market

Get a free sample of this report